Cited by 1,791Nanoparticle-Based Drug DeliveryProtein Interaction Studies and Fluorescence AnalysisGold and Silver Nanoparticles Synthesis and Applications

Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy

Open access
Aggarwal, Parag, Hall, Jennifer B., McLeland, Christopher B., Dobrovolskaia, Marina A., McNeil, Scott E.·2009·Advanced Drug Delivery Reviews

Abstract

Proteins bind the surfaces of nanoparticles, and biological materials in general, immediately upon introduction of the materials into a physiological environment. The further biological response of the body is influenced by the nanoparticle-protein complex. The nanoparticle's composition and surface chemistry dictate the extent and specificity of protein binding. Protein binding is one of the key elements that affects biodistribution of the nanoparticles throughout the body. Here we review recent research on nanoparticle physicochemical properties important for protein binding, techniques for isolation and identification of nanoparticle-bound proteins, and how these proteins can influence particle biodistribution and biocompatibility. Understanding the nanoparticle-protein complex is necessary for control and manipulation of protein binding, and allows for improved engineering of nanoparticles with favorable bioavailability and biodistribution.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.addr.2009.03.009

Cites

139 of 139 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Properties such as size, surface charge, hydrophobicity/hydrophilicity, and steric effects of particle coating influence compatibility of nanoparticles with immune system.

    “Additionally, the properties such as size, surface charge, hydrophobicity/hydrophilicity, and the steric effects of particle coating have influence on the compatibility of nanoparticles with the immune system [147–150].”
  • Formation of specific antibodies against nanoparticles may affect efficacy and safety of nanoparticle-based therapeutics.

    “It is worth noting that formation of specific antibodies against nanoparticles may affect the efficacy and the safety of nanoparticle-based therapeutics [149, 150].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E.
Affiliations
Science Applications International Corporation (United States) (US)
Corresponding author
Dobrovolskaia, Marina A.
Venue
Advanced Drug Delivery Reviews
Publisher
Elsevier BV
Published
2009-06
Volume
61
Issue
6
Pages
428-437
ISSN
0169-409X (ISSN-L)
OpenAlex
W2021876818
Cited by
1,791
References
139
Citations by year
2026: 42 · 2025: 72 · 2024: 73 · 2023: 80 · 2022: 111 · 2021: 129 · 2020: 148 · 2019: 145 · 2018: 129 · 2017: 137 · 2016: 158 · 2015: 137 · 2014: 133 · 2013: 103 · 2012: 85
FWCI
3.06
Type
journal article
Language
en
Open access
Locations
  • Advanced Drug Delivery Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (n01co12400-79-0-22, HHSN261200800001C)
  • National Cancer Institute (N01CO12400, N01-CO-012400, HHSN261200800001E))
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
  • Physical Sciences › Materials Science › Electronic, Optical and Magnetic Materials › Gold and Silver Nanoparticles Synthesis and Applications
Keywords
protein-nanoparticle binding, plasma proteins, nanoparticle biodistribution, biocompatibility, nanoparticle surface chemistry, nanoparticle physicochemical properties, protein binding specificity, bioavailability, treatment efficacy
MeSH terms
Animals, Blood Proteins, Drug Carriers, Humans, Kinetics, Protein Binding, Tissue Distribution, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review